Carlsmed Appoints Richard Heppenstall as Chief Financial Officer

Company Reaffirms Fiscal Year 2026 GuidanceCARLSBAD, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. NASDAQ:CARL (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that Richard Heppenstall has been appoin…